DCAL167.18

Dishman Carbogen Amcis Limited

· Pharma & Health
₹ CrorePeersHIKALSOLARAPANACEABIOINDSWFTLABSAIPARENTINDOCOSMSPHARMAWINDLASMcap ₹2,621 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
DCAL
FY26
HIKAL
FY26
SOLARA
FY26
PANACEABIO
FY26
Peer
Median
Valuation — at last close
P/E26.88×
P/B0.39×2.41×2.50×2.87×2.50× -84%
EV/EBITDA8.12×16.16×20.34×-501.02×16.16× -50%
Market Cap₹2,621 Cr₹2,891 Cr₹3,142 Cr₹2,378 Cr₹2,891 Cr -9%
Growth
Revenue CAGR 3Y6.71%-5.40%-1.76%11.63%-1.76% +481%
Revenue CAGR 5Y8.93%-0.09%-3.27%0.47%-0.09% +10022%
Revenue YoY (latest Q)-4.29%5.89%19.57%19.72%19.57% -122%
Net Income YoY (latest Q)-347.24%66.96%55.04%-44.44%55.04% -731%
Profitability
EBITDA Margin19.29%12.87%13.64%-0.73%12.87% +50%
Net Income Margin3.32%-2.85%-0.54%-1.12%-1.12% +396%
Return on Common Equity1.46%-4.07%-0.59%-0.65%-0.65% +325%
Return on Capital Employed2.36%3.36%6.05%-4.13%3.36% -30%
Return on Assets0.82%-2.06%-0.32%-0.57%-0.57% +244%
Credit & Quality
Total Debt/Equity0.42×0.57×0.53×0.03×0.53× -21%
Interest Coverage1.30×0.91×0.92×-6.23×0.91× +43%
Scale — latest FY
Revenue / Total Income₹2,932 Cr₹1,713 Cr₹1,369 Cr₹640 Cr₹1,369 Cr +114%
Net Income₹97.5 Cr−₹48.8 Cr−₹7.4 Cr−₹7.2 Cr−₹7.4 Cr +1415%
Total Assets₹11,923 Cr₹2,365 Cr₹2,333 Cr₹1,262 Cr₹2,333 Cr +411%
EPS₹6.22₹-3.96₹-1.68₹-0.88₹-1.68 +470%
Book Value per Share₹425.82₹97.07₹282.08₹135.22₹135.22 +215%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.